NextFin News — Unitree Robotics began online and offline subscription for its Shanghai STAR Market initial public offering on Monday at an issue price of 150.80 yuan per share.
The company is offering 40.446434 million shares, representing 10 percent of post-issue share capital, and expects to raise about 6.099 billion yuan before expenses, or a net 5.917 billion yuan. Payment is due Aug. 12. The offering implies a market capitalization of roughly 61 billion yuan and includes strategic placement to investors such as the National Social Security Fund and the parent of DeepSeek.
Unitree, a Hangzhou-based maker of humanoid and quadruped robots, reported more than 5,500 humanoid units shipped in 2025, ranking first globally, alongside cumulative sales of over 33,000 quadrupeds. Proceeds will largely fund research into intelligent robot models, body development, new product lines and a manufacturing base designed to lift annual capacity to 75,000 humanoid and 115,000 quadruped robots. The listing marks the first major A-share debut of a pure-play humanoid robot producer.
Explore more exclusive insights at nextfin.ai.
Insights
What does Unitree Robotics' STAR Market IPO reveal about China's humanoid robot industry?
How does the STAR Market listing process work for high-tech robotics companies like Unitree?
What technologies are behind Unitree's humanoid and quadruped robots?
Why is Unitree considered the first major A-share pure-play humanoid robot listing?
How strong is current investor demand for robotics IPOs in China's public markets?
What do Unitree's shipment and sales figures suggest about current market demand?
How are strategic investors such as the National Social Security Fund shaping confidence in Unitree?
How does Unitree compare with other global humanoid robot companies in scale and commercialization?
What recent trends are driving funding and public listings in the robotics sector?
How will Unitree use IPO proceeds for robot models, new products, and manufacturing expansion?
What challenges could Unitree face in expanding annual production capacity after the IPO?
What are the biggest technical and commercial hurdles in scaling humanoid robot production?
Could Unitree's valuation create debate about pricing and profitability in the robotics industry?
What role might intelligent robot models play in Unitree's future product development?
How could this IPO influence future financing plans for other Chinese robot makers?
What long-term impact could Unitree's public listing have on competition in global robotics?
